Study pointing to the importance of combo-therapy for HepB

Below is the address to a recent study pointing to the importance to combo-therapy to prevent antiviral resistance:

http://www.ncbi.nlm.nih.gov/pubmed/18328434?dopt=Abstract

And here is part of the abstract:

"Preventing HBV antiviral drug resistance to nucleoside/nucleotide analogues and appropriate management when resistance occurs has become a major focus in the management of chronic hepatitis B. HBV antiviral drug resistance may be best prevented by using an agent or combination of agents with a high genetic barrier to resistance, and 2 potent nucleoside and nucleotide drugs with different resistance profiles may prove to be the optimal first-line treatment for chronic hepatitis B."

[stevenNYer]

Here's a new law at this forum.  ALL threads must have at least 1 reply !  By the order of the purple flower!

Yeah, yeah, yeah,  I finally lost it.